Business RadioX ®

  • Home
  • Business RadioX ® Communities
    • Southeast
      • Alabama
        • Birmingham
      • Florida
        • Orlando
        • Pensacola
        • South Florida
        • Tampa
        • Tallahassee
      • Georgia
        • Atlanta
        • Cherokee
        • Forsyth
        • Greater Perimeter
        • Gwinnett
        • North Fulton
        • North Georgia
        • Northeast Georgia
        • Rome
        • Savannah
      • Louisiana
        • New Orleans
      • North Carolina
        • Charlotte
        • Raleigh
      • Tennessee
        • Chattanooga
        • Nashville
      • Virginia
        • Richmond
    • South Central
      • Arkansas
        • Northwest Arkansas
    • Midwest
      • Illinois
        • Chicago
      • Michigan
        • Detroit
      • Minnesota
        • Minneapolis St. Paul
      • Missouri
        • St. Louis
      • Ohio
        • Cleveland
        • Columbus
        • Dayton
    • Southwest
      • Arizona
        • Phoenix
        • Tucson
        • Valley
      • Texas
        • Austin
        • Dallas
        • Houston
    • West
      • California
        • Bay Area
        • LA
        • Pasadena
      • Colorado
        • Denver
      • Hawaii
        • Oahu
  • FAQs
  • About Us
    • Our Mission
    • Our Audience
    • Why It Works
    • What People Are Saying
    • BRX in the News
  • Resources
    • BRX Pro Tips
    • B2B Marketing: The 4Rs
    • High Velocity Selling Habits
    • Why Most B2B Media Strategies Fail
    • 9 Reasons To Sponsor A Business RadioX ® Show
  • Partner With Us
  • Veteran Business RadioX ®

To Your Health With Dr. Jim Morrow: Episode 13, Medical Marijuana in Georgia, An Interview with Justin Hawkins and Dr. Scott Cooper, Acreage Compass, LLC

July 24, 2019 by John Ray

North Fulton Studio
North Fulton Studio
To Your Health With Dr. Jim Morrow: Episode 13, Medical Marijuana in Georgia, An Interview with Justin Hawkins and Dr. Scott Cooper, Acreage Compass, LLC
Loading
00:00 /
RSS Feed
Share
Link
Embed

Download file

Dr. Scott Cooper, Dr. Jim Morrow, and Justin Hawkins

Episode 13, Medical Marijuana in Georgia

How does the new Georgia law (HB 324) allowing prescribed use of medical marijuana work? Is medical marijuana a slippery slope to recreational marijuana use? In a conversation with host Dr. Jim Morrow, Justin Hawkins and Dr. Scott Cooper of Acreage Compass LLC answer these questions and more. “To Your Health” is brought to you by Morrow Family Medicine, which brings the CARE  back to healthcare.

Justin Hawkins and Dr. Scott Cooper, Acreage Compass, LLC

Dr. Scott Cooper and Justin Hawkins, Acreage Compass, LLC

Justin Hawkins is the General Manager and Dr. Scott Cooper is the Medical Affairs Director of Acreage Compass LLC. Acreage Compass is jointly owned by Compass Neuroceutical, Inc., a Georgia-based team of physicians, advocates, and patients, and Acreage Holdings, the largest vertically integrated, multi-state owner of cannabis licenses and assets in the United States. Through Acreage Compass, Compass Neuroceutical and Acreage Holdings are partnering to bring safe and consistent medical cannabis oil to patients in the state of Georgia.

For more information go to their website or email Justin Hawkins at justin@compassneuro.com.

About Morrow Family Medicine and Dr. Jim Morrow

Morrow Family Medicine is an award-winning, state-of-the-art family practice with offices in Cumming and Milton, Georgia. The practice combines healthcare information technology with old-fashioned care to provide the type of care that many are in search of today. Two physicians, three physician assistants and two nurse practitioners are supported by a knowledgeable and friendly staff to make your visit to Morrow Family Medicine one that will remind you of the way healthcare should be.  At Morrow Family Medicine, we like to say we are “bringing the care back to healthcare!”  Morrow Family Medicine has been named the “Best of Forsyth” in Family Medicine in all five years of the award, is a three-time consecutive winner of the “Best of North Atlanta” by readers of Appen Media, and the 2019 winner of “Best of Life” in North Fulton County.

Dr. Jim Morrow, Morrow Family Medicine, and Host of “To Your Health With Dr. Jim Morrow”

Dr. Jim Morrow, Morrow Family Medicine, and Host of “To Your Health With Dr. Jim Morrow”

Dr. Jim Morrow is the founder and CEO of Morrow Family Medicine. He has been a trailblazer and evangelist in the area of healthcare information technology, was named Physician IT Leader of the Year by HIMSS, a HIMSS Davies Award Winner, the Cumming-Forsyth Chamber of Commerce Steve Bloom Award Winner as Entrepreneur of the Year and he received a Phoenix Award as Community Leader of the Year from the Metro Atlanta Chamber of Commerce.  He is married to Peggie Morrow and together they founded the Forsyth BYOT Benefit, a charity in Forsyth County to support students in need of technology and devices. They have two Goldendoodles, a gaggle of grandchildren and enjoy life on and around Lake Lanier.

Facebook: https://www.facebook.com/MorrowFamMed/

LinkedIn: https://www.linkedin.com/company/7788088/admin/

Twitter: https://twitter.com/toyourhealthMD

Show Transcript

Intro: [00:00:06] Broadcasting live from the North Fulton Business RadioX Studio, it’s time for To Your Health with Dr. Jim Morrow. To Your Health is brought to you by Morrow Family Medicine, an award winning primary care practice, which brings the care back to health care.

Dr. Jim Morrow: [00:00:23] Hello! This is Dr. Jim Morrow. I’m with Morrow Family Medicine. We have offices in Cumming and Milton, Georgia. We’re a primary care practice, where we utilize state-of-the-art technology and old-fashioned ideas to bring you the best care we possibly can. We believe that in Morrow Family Medicine, you’ll feel both cared for and appreciated. And we do realize that you have many choices as to where you receive your care, and we hope you’ll find that Morrow Family Medicine is a good place for you.

Dr. Jim Morrow: [00:00:51] I’m here in the studio at Renasant Bank on Windward Parkway in Alpharetta, Georgia with John Ray, my cohort. John’s running the board. How are you doing, John?

John Ray: [00:00:59] I’m great. I hope you’re well today.

Dr. Jim Morrow: [00:01:01] I’m good. It’s not too hot outside today. So, those are pretty good.

John Ray: [00:01:04] Perfect in Alpharetta and Milton

Dr. Jim Morrow: [00:01:07] Always sunny in Alpharetta, right?

John Ray: [00:01:09] Yeah, you got it.

Dr. Jim Morrow: [00:01:11] So, we’re here today for another podcast. We want you to know that you can reach out to us by e-mail at drjim@toyourhealth.md or or you can tweet us, @toyourhealthmd.

Dr. Jim Morrow: [00:01:24] So, we’re here today to talk about cannabis oil and low-THC oil, what some people refer to as medical marijuana in the State of Georgia. And I’m honored to have two guests with me today from Acreage nchorage Compass LLC. We have Justin Hawkins, the General Manager, and Dr. Scott Cooper, who’s the Medical Affairs Director. Hello, gentlemen. How are you today?

Dr. Scott Cooper: [00:01:48] Doing well, thank you.

Justin Hawkins: [00:01:49] I’m good. How are you? I, actually, have both of my doctors here. So, I don’t know if this is an intervention or an interview, but it’s good to be here.

Dr. Jim Morrow: [00:01:55] We’re going to get into that later, Justin. You can count on it. You can count on it. So, this whole thing has started up in Georgia fairly suddenly. If you haven’t been following the news and haven’t followed the path of low-THC oil in Georgia, there is a bill, House Bill 324 that was passed by the state legislature and signed by the governor at the beginning of April of this year. So, Justin, tell us something about House Bill 324.

Justin Hawkins: [00:02:23] Yes. So, House Bill 324 is a piece of legislation that has been tried over the last six years. And we were successful this year in 2019 under the leadership of Brian Kemp. And what House Bill 324 does is it allows the cultivation, and processing, and distribution of low-THC oil, which is 5% THC in cannabis oil, also referred to as medical marijuana.

Justin Hawkins: [00:02:46] The reason that we wanted to push House Bill 324 is because over the last six to seven years, medical cannabis oil was legal for possessions for qualified patients under the Georgia Department of Health, but there was no real legal access for these patients under these 17 indication list to actually acquire the medicine.

Justin Hawkins: [00:03:06] And so, although medical cannabis is actually illegal under federal law, we’ve seen across the entire country that in over 33 — over 43 states across the country that in-state cultivation is a way that provides medicine to patients, also, by abiding by state law. And so, that’s what House Bill 324 does specifically.

Dr. Jim Morrow: [00:03:25] Well, why was it able to be passed this year when it wasn’t able to be passed the other year?

Justin Hawkins: [00:03:30] So, we were fortunate for a couple of different reasons. Georgia Hope is an organization founded by parents. A lot of the times, they’re parents of these kids who suffer from pediatric epilepsy, mitochondrial disease, autism, and they have really led the fight over the last six years. Fortunately, under the leadership, the new leadership, of Governor Brian Kemp and Jeff Duncan, along with public opinion and the way that we’ve seen the research of these in-state cultivation programs being analyzed, all of that came together in a positive way that said, you know, in-state cultivation is a way for kids, and veterans, and all other patients to get medicine. It’s not going to change the culture of Georgia. And I think between that and between organizations like the one Dr. Cooper and I founded, all of us coming together and moving in one step, really, it was everything coming together at once and we were thankful for it.

Dr. Jim Morrow: [00:04:21] Super. And the law allows for specifics about who can grow this, and cultivate it, and produce it, and so forth. Can you talk some about who, and what, and how many companies, and so forth are going to be involved in it?

Justin Hawkins: [00:04:37] Yeah, we anticipate there’s going to be a lot of interest. Georgia is the eighth most populous state in the nation. It has a huge market, and there’s a lot of patients that are on the registry – 10,000 when we passed the bill, 300 we’re adding per month with no change to the legislation. So, we do believe that in the market of Georgia, it’s a large market. So, from an industry standpoint, there’s going to be a lot of companies and employers interested. What the bill allows specifically, it allows two class 1 organizations with a higher financial stipulation to prove to the state that they have. And it also allows four class 2, which are for smaller entities, small business across the state of Georgia. Those are six private licenses. Now, aside from that, they did allow two university programs to research, and develop, and cultivate. And that’s what the University of Georgia and Fort Valley State University down the south of Atlanta. And so, when you combine, a total of eight enterprises, public and private, that’s who will be the structure of Georgia medical cannabis.

Dr. Jim Morrow: [00:05:38] Interesting. So Georgia’s law, being one of the newer ones, can you tell me how this law is different from the laws in these other states that you mentioned?

Justin Hawkins: [00:05:47] Yeah. So, for instance, I’d like to take the obvious, which is Colorado. So, when you look at Colorado, which passed medical cannabis back in 2000-2001, the way we were different and the largest way that I can contrast between is horizontal versus vertical. And what I mean by that is when you look at Colorado, they allowed a horizontal structure, which means they allowed growers, processors, and distributors, all being separate silos, so to speak. What we did in Georgia is not only do we put a THC cap of no more than 5%, which is very low THC, but what we also did is we allowed vertical integration, which means that the companies vying for these class 1 and class 2 licenses is that they grow, they process, and they distribute their own product.

Justin Hawkins: [00:06:30] And why we feel like that’s very valuable for the State of Georgia is it allows high-quality control. It allows players and companies that know what they’re doing. They have a track record across the country. It allows us to not have price increases with middlemen. So, we’re allowed to go directly to the patient. Obviously, you guys are doctors. You guys know how the pharmaceutical industry works. So, it’s almost like if Johnson & Johnson or Amgen had their own pharmacies, that’s what our company is vying to do.

Dr. Jim Morrow: [00:06:58] Okay. And you called it low-THC oil. And a lot of listeners hearing THC, they’re going to think that this is something that’s going to act and function like marijuana. So, Dr. Cooper, what exactly is low-THC oil?

Dr. Scott Cooper: [00:07:13] It restricts how much THC is in the compound. And let me read you something from the AMA since you bring that up.

Justin Hawkins: [00:07:22] While he’s doing that, I can give you kind of an overview. So, when it comes to low-THC oil, what we have is we have hemp-derived oil, and we have cannabis-derived oil. Hemp-derived oil is what’s often referred to as CBD. And so, you see CBD on the market because hemp CBD oil is now federally legal with the Farm Bill that was passed a couple months ago. With cannabis, you have cannabis oil. And so, when you have natural cannabis, it can be as high as 90%. And so what Dr. Cooper will talk about specifically is that when we form cannabis oil from the actual cannabis plant, then we’re restricting that THC down to 5% per milliliter. And so, that’s what allows us to have different indications. And he’ll speak more to that.

Dr. Scott Cooper: [00:08:05] Sorry for that delay. I didn’t have it prepared for you. So, this is a quote from the FDA stating that it is THC and not CBD that’s the primary psychoactive compound of marijuana. And they approved a medication with low THC for specific seizure disorders, primarily in children. And they approved, and I quote, “They’re committed to this kind of careful scientific research and drug development, continuing to support rigorous scientific research on potential uses of medical marijuana-derived products.” So, we’re not talking about something that is psychoactive. This compounds specifically for specific and, in the case of Georgia, 17 discrete different disease states.

Dr. Jim Morrow: [00:08:51] And these are disease states that have had faulty, not effective medications and treatment methodologies previously pretty much.

Dr. Scott Cooper: [00:09:00] Absolutely. They have done studies with veterans, as well as studies with geriatric patients and chronic pain syndrome. And they found that even in senior citizens, it reduced the opiate use by over one-third. So, we’re looking for a safe medication without the side effects and addictive properties of current therapies that we have for different disease states right now.

Justin Hawkins: [00:09:25] And we say this all the time, it’s not a miracle drug. Dr. Cooper, you’re great at saying this. It’s more of an adjunct. And so, we see a lot of combined with pharmaceutical drugs, it really does make a difference.

Dr. Scott Cooper: [00:09:35] Yeah, this is not going to be replacing every medication that somebody is out there taking right now. This is to help them get over the hump to really control whatever disease state we’re talking about.

Dr. Jim Morrow: [00:09:45] So, in Georgia, the process for acquiring a card, which as I understand is what you have to have to get this, tell me a little bit about the process for going through that.

Dr. Scott Cooper: [00:09:57] Well, the physician, (1), who’s prescribing it has to be registered with the state. So, that’s the first hurdle. Not every physician wants to participate in the program. Then, (2), they have specific paperwork that needs to be filled out and sent in to the Georgia Department of Health. The patient has to be registered, and the patient gets a registration card. And it’s presumed right now it’s not definitely set, but we suppose that this is going to be similar to other states where there will little bit discreet dispensaries specifically for CBD products, and the patient has to present that card to be able to achieve and get the medication.

Dr. Jim Morrow: [00:10:38] And there’s a limit, I’m sure, on how much any particular person can have in their possession at any one time.

Dr. Scott Cooper: [00:10:44] Absolutely. Not just how much they can have at one time in their possession, but how much they can purchase over a 30-day period. And you would have to drink gallons of this stuff to try to get high. So, if you’re going to spend over $100 per bottle, you’re better off doing something illegally if you’re in search of something that’s psychoactive. If high is your goal, you’re not going to get it here.

Dr. Jim Morrow: [00:11:08] So, you take the THC oil, in the case of seizures, let’s say it helps to control the seizures. Do we know how that works in the brain?

Dr. Scott Cooper: [00:11:17] No, we don’t. Yeah, I wish we did. There are a lot of different cannabidiol receptors. We know that what’s available now commercially for these two seizure types, the Epidiolex, does not work for pain disorders or tic disorders. There are two compounds right now in Europe and in Canada that are used for multiple sclerosis-associated pain, as well as cancer-associated pain. And it’s within that realm of cannabis, but it’s a different level of THC. So, there have to be different products specifically developed for different disease states. But yet, we’re at the stage where we know it works, but we don’t know how at this point.

Dr. Jim Morrow: [00:12:01] Well, the results that you see and the stories that you hear about the most heart-wrenching ones are children with disease processes and seizures is a great example are just absolutely mind blowing when you see what this medicine can do for them and what their traditional medicines have not done for them. So, I think it’s a very exciting time.

Dr. Scott Cooper: [00:12:24] That’s absolutely right. I’ll be honest, I was a skeptic when this first came out and was not willing to endorse it, and had patients that were acquiring from other states illegally. And they came in, and their seizures were dramatically reduced. Not controlled, but reduced, such that I could reduce some of the medications that were both expensive, as well as having side effects. And then, saw other patients with autism. Their behavior improved. Parkinson’s disease, tremor improved. Alzheimer’s disease, behavior improved. And that’s when I started looking into it more, and then became an advocate.

Dr. Jim Morrow: [00:13:01] So, the law gets passed. The science says this will work for a variety of different instances. You mentioned 17 different diagnoses that it can be used for. So, along comes Justin and Scott Cooper. And how does this happen that you ended up being in this push to, now, produce and to distribute THC?

Justin Hawkins: [00:13:25] As we were talking earlier, when you look at anybody in this industry, they have a touchpoint. Either they have a family member, or they have a neighbor, or they have a patient that comes to them, and you see them suffering. So, for me, my brother served overseas in Iraq and Afghanistan, and I saw him come back from overseas, and work with the VA. And instead of being on a medication, like a tool like low-THC oil, he was on opiates. And that led to a whole different battle of its own.

Justin Hawkins: [00:13:51] And so, I was very interested from that point. And so, in 2018, Dr. Scott Cooper, and myself, and six other partners around the State of Georgia formed Compass Neuroceutical, which was an advocacy group, all Georgia-based, with a single focus, which was to pass House Bill 324. In doing so, because we were successful with one other company in supporting Georgia Hope, which was the organization with parents, patients, and advocates that have been fighting for this for six years, we all came together. We were successful in passing it.

Justin Hawkins: [00:14:19] Simultaneously, we were talking to national leaders about partnering and having a specific partnership within the State of Georgia to to be a licensed holder and to lead the way in Georgia, so that we could be the standard bearer for the country. And in doing so, we talked to many of the national leaders, and we were fortunate to choose a company known as Acreage Holdings, which is the largest multi-state owner and operator in the United States. They have a great executive leadership team with the board of directors, folks like the former Speaker of the House, John Boeher, former Prime Minister of Canada, Brian Mulroney, governors and former CEOs of international companies.

Justin Hawkins: [00:14:57] And why that matters is you see in this industry, and I tell people all the time, they think I’m joking, but I’m really serious, this industry is either Warren Buffett all the way to-

Dr. Jim Morrow: [00:15:06] Thomas Leary.

Justin Hawkins: [00:15:10] Thomas Leary. All the way to Willie Nelson and in between. And so, the industry is very wide. So, we do a lot of different things. We have good governance and integrity, and we keep stupid away. But on top of that, we have a proven track record of owning more licenses. 20 states, we have 88 licenses across the country. And because we’re the largest, we know how to get safe, reliable product in a quick and efficient manner to patients. And so, with that partnership, we have created what’s now called Acreage Compass LLC, which will be vying for a Class 1 license in the State of Georgia.

Dr. Scott Cooper: [00:15:41] Yeah, if I could add that Georgia Hope was the main thrust behind this. As Justin said, we were able to work with them to finally get it over the finish line. And all of these companies are just drooling over starting business in Georgia. And we were approached by numerous corporations that are in the industry. And we selected the one that we thought had the same vision we do because there are others that are out there that are just interested as this is a bridge to recreational marijuana, and that they really saw medical marijuana as a stepping stone, but they weren’t very interested in the cultivation and in studying which drug combination was going to be best for which disease state. And Acreage has integrity, which is something you don’t see in every partner that was searching out their.

Dr. Jim Morrow: [00:16:31] So, with the passage of the bill, the State is creating this commission, the Cannabis Commission, basically, that will choose these companies. What’s that process like for being chosen? I know you’re doing an awful lot of work, both of you, with Acreage Compass right now in hopes of being selected, but nothing’s written in stone. So, tell me about the process, the timeline, and how you expect all that to happen.

Justin Hawkins: [00:16:56] Yeah. We’re kind of on hold now. I know, Governor Brian Kemp, Lieutenant Governor Jeff Duncan, Speaker David Ralston are doing a whole lot behind the scenes to make sure that a commission is set up in an appropriate way that really has the spear in the integrity of the bill. And so, as of now, the commission is set up – three appointed by the governor, two appointed by the lieutenant governor, and two appointed by the speaker. So, a total of seven appointees to the commission.

Justin Hawkins: [00:17:20] Within the three that the governor has, one of those will be the chair of the commission. In doing so, the commission creates one position under them immediately as the executive director of the commission, which handles the daily functions. This whole commission will be under the Secretary of State’s office as the regulator moving forward in the future.

Justin Hawkins: [00:17:39] So, we’re on hold right now. None of the commission members have been selected. We anticipate from our talks. Of course, this can change between August and September of the appointees being selected. From that process. when they’re selected, they really start from ground up, which means they create the rules and regulations, the application, the criteria. And then, from that point, then private companies are able to do the application, which is a very stringent process. Some are even over 3000 pages from that timeline. Then, three to six months after the applications are submitted, we anticipate the state will then choose which licence holders they feel are competent based on a variety of factors.

Dr. Jim Morrow: [00:18:20] So, you mentioned 10,000 people on the registry now, adding about 300 a month. So, I think, earlier, when we were talking, you said the expectation is a quarter million people on the registry.

Justin Hawkins: [00:18:33] I was talking, when Representative Micah Gravley spoke at our Rotary Club not too long ago, I went out to dinner with him the night before to talk about the different things we could do to work together and other stakeholders. And he had relayed, and we feel very strongly that by the end of next year, we’re almost going to see 50,000 patients in the registry. And it just shows — you saw a lot before House Bill 324 passed that many patients in the 17 indication list were not even registering because there was no real access to acquire this medication. With that, we had 645 doctors as soon as we passed House Bill 324 that were on the registry.

Justin Hawkins: [00:19:11] So, we anticipate both those numbers will dramatically increase. I would argue that about a quarter of a million patients will be registered in Georgia over the next four to five years. And I would even say that’s a conservative estimate. And that’s not to say that this program gets out of control. That’s to say that these, from mitochondrial disease, to autism, to pediatric epilepsy, to PTSD, these are disease states that are large, so to speak. And I know Dr. Cooper can speak to that, but we believe that Georgia is a large market, and it’s been underserved over the last 10 years.

Dr. Scott Cooper: [00:19:47] Yeah, I would have to agree with that. I’d say that, at least, one or two times a day, I have patients that are telling me either they’re already on it, and how do they get a card, or how do they acquire it? People are asking about it. And there were some opponents to the bill who said, “Well, you only have so many people on the registry, so it’s not going to be used.” And I likened that to saying, “Well, the bill hadn’t been passed yet.” So, that’s like saying, “Okay, I see a sign saying Kroger is opening up. When are they opening? And you’re assuming only the people who asked about the sign are going to be future customers.” And the store opens, and, suddenly, you have 100,000 customers. Right. So, I think that once we have the distribution set up and the physicians signed up, that we’re going to see easily well over 100,000 patients within the first year.

Dr. Jim Morrow: [00:20:35] And the patients, those patients will be for these disease processes that are already approved. What does the future of cannabis oil and cannabis, in general, look like medically?

Dr. Scott Cooper: [00:20:46] There are more and more studies that are going on all the time. A lot of them under federal funds. And then, you’ve got the two colleges, universities that will be pursuing some research. Right now, the Georgia Department of Health is the one that regulates which disease states are approved and how many. And they went from seven in one year to 17 the next year. I’m sure, as we gain more experience, we’re going to see future applications beyond what we have right now.

Dr. Jim Morrow: [00:21:15] Okay. So, we’re talking with Justin Hawkins and Dr. Scott Cooper from Acreage Compass, LLC. And Justin, I want to ask you before we go, is  there a way that people can do their own research? Is there a way they can learn something about your company and the business in general?

Justin Hawkins: [00:21:32] Yeah, absolutely. We have our own website, compassneuro.com. That will have information coming out in the next weeks. And then, also acreageholdings,com, which kind of gives you a layout of who Acreage is. We’re in over 20 states across the entire country. We have a public potential merger with a company called Canopy Growth, which is the largest cannabis company in the entire world. And so, the proprietary information that we have, the assets, and the intellectual property, and knowledge is second to none. And so, those two websites are great resources. Dr. Scott Cooper and I live in the Atlanta area. So, we’re always around to answer questions. We’d like to meet patients. We see all the time these children and parents who have been suffering, don’t know what to do. And so, if there’s any of that case, we’re here to to help any way we can.

Dr. Jim Morrow: [00:22:21] Super. John, you’ve been awfully quiet over there. And we have anybody that sent us any questions or comments during our time here?

John Ray: [00:22:32] You’ve got them all stirred up again.

Dr. Jim Morrow: [00:22:34] I like that.

John Ray: [00:22:36] Yeah,.

Dr. Jim Morrow: [00:22:36] If it’s not disease, this or vaccine.

John Ray: [00:22:37] Vaccines. I thought vaccines hit the high watermark, but I think you got it going again today. So, several questions about the — is this a slippery slope to recreational use?

Dr. Jim Morrow: [00:22:52] That’s a great question. Scott, I’ll send that to you. What do you think? If people start using THC, it will going out behind the Wal-Mart and looking for marijuana to buy?

Dr. Scott Cooper: [00:23:03] Well, not only is this my opinion, but actually a study was just published with over 1.4 million people that were surveyed throughout the entire United States. And in the 33 states, plus the District of Columbia, there was not a single area geographically that there seemed to be a breakthrough for low THC, and then they convert over to recreational. This has been disproven conclusively that this is not a gateway drug to tempt people to, then, go to recreational drugs such as marijuana or other types of substance abuse.

Justin Hawkins: [00:23:40] And if I could add one thing, we did one thing different than a lot of states. And Micah Gravley, who’s the author of House Bill 324, with Senator Matt Brass, really pushed this with Governor Brian Kemp. And it was a great way to contrast ourselves to other states who have gone to recreation. If you look at every state that started as a medical program that goes to recreation, they had one thing in their program that Georgia does not. And that’s the ability to have smokable flower. So, with states like Colorado, or California, or Oregon, or Washington, they had smokable flower in their medical program. Not only does Georgia not allow smoking smokable flower, but we don’t allow vaping as well. So, that’s a main difference that we saw, a common denominator.

Dr. Jim Morrow: [00:24:24] Super. That’s a great question, John.

John Ray: [00:24:27] I only ask great questions.

Dr. Jim Morrow: [00:24:31] We’ll talk about that off the air!

John Ray: [00:24:31] Yeah, okay. I’ve got one more if I can try again.

Dr. Jim Morrow: [00:24:35] Sure.

John Ray: [00:24:35] Let’s see if this is a great one too.

Dr. Jim Morrow: [00:24:37] Yeah.

John Ray: [00:24:37] So, the question relates to side effects. So, all medications have some sort of side effects. Are there any other side effects noted in the use of this THC oil?

Dr. Scott Cooper: [00:24:51] If you read the print out for Tylenol, you’ll see a yard-full of potential side effects. You do not need to monitor any blood tests routinely with this low-THC oil. It can have a little bit of a calming side effect and, sometimes, a little bit of sedation, but that’s about it. So, it’s not the high THC that you see with recreational, so you’re not going to get the munchies.

Dr. Jim Morrow: [00:25:18] That’s good.

Dr. Scott Cooper: [00:25:21] As opposed to other drugs, either a lot of marijuana or methamphetamines that lower the seizure threshold, this actually treat seizures.

Dr. Jim Morrow: [00:25:31] Well, that’s wonderful. If you have a medicine that can treat the things we’re talking about that are difficult to treat, and it doesn’t affect your liver, your kidneys, it’s not mood altering or habit-forming, they don’t drug test for in a workplace, that kind of thing, then I think that’s great. And, of course, there’s a new drug test for it, but with the prescription card, is a negative drug screen.

Dr. Jim Morrow: [00:25:48] So, I think that’s a fantastic thing. And I’m very excited as a practicing physician about seeing where this will go. And I’m very excited as a businessman by seeing where you guys go. So, I really appreciate you all being here very much. I think, John, we’re going to wrap it up for today.

John Ray: [00:26:04] Sounds good.

Dr. Jim Morrow: [00:26:05] All right. This is To Your Health.

Tagged With: Crohn's disease, Cumming family doctor, Cumming family medicine, Cumming family physician, Cumming family practice, Cumming md, Dr. Jim Morrow, Dr. Scott Cooper, end stage cancer, epilepsy, GA House Bill 324, Georgia Access to Medical Cannabis Commission, Georgia's medical marijuana law, Hemp, hemp-derived oil, in hospice program, intractable pain, low-THC oils, medical cannabis, Medical Marijuana, medical marijuana prescription, medical marijuana program, Milton family doctor, Milton family medicine, Milton family physician, Milton family practice, Milton md, Mitochondrial Disease, Morrow Family Medicine, Parkinsons Disease, post-traumatic stress disorder, recreational marijuana use, seizures, tetrahydrocannabinol, Tourette's syndrome

To Your Health With Dr. Jim Morrow: Episode 10, Colon Cancer Screening, An Interview with Dr. Simon Confrancesco

June 12, 2019 by John Ray

North Fulton Studio
North Fulton Studio
To Your Health With Dr. Jim Morrow: Episode 10, Colon Cancer Screening, An Interview with Dr. Simon Confrancesco
Loading
00:00 /
RSS Feed
Share
Link
Embed

Download file

Dr. Jim Morrow and Dr. Simon Cofrancesco

Episode 10, Colon Cancer Screening

Statistics show that colon and rectal cancers are the second biggest cancer killer, yet unlike most cancers, this disease is preventable with proper screening. On this episode of “To Your Health with Dr. Jim Morrow,” Dr. Morrow welcomes gastroenterologist Dr. Simon Cofranceso to the show to get the lowdown on colon cancer screening. “To Your Health” is brought to you by Morrow Family Medicine, which brings the CARE back to healthcare.

Dr. Simon Confrancesco, GI North

Dr. Simon Cofrancesco

Dr. Simon Cofrancesco is a board certified gastroenterologist with over 25 years of experience.  Dr. Cofrancesco is originally from Massachusetts. He completed his medical training at Baystate Medical Center of the Tufts University School of Medicine, followed by a Fellowship in Gastroenterology at Long Island College Hospital in Brooklyn.

Dr. Cofrancesco began his career in an underserved area of Mississippi as part of his school loan repayment. He worked at Southwest Mississippi Regional Medical Center in McComb, Mississippi, for over sixteen years and was named Chief of Staff in 2007. While in Mississippi, he met his wife Roxanna Redden, and they started their family of 5 children, ages 10-19.

Dr. Cofrancesco then moved to Georgia and founded GI North in 2011, followed by GI North Endoscopy in 2018.  GI North has steadily grown and currently has 3 additional providers including two additional gastroenterologists and a GI nurse practitioner.  GI North is physician owned and operated, and because of their commitment to patient centered care has been awarded “Best of Forsyth” in 2017 and 2018.   For further information on GI North you can go to their website at gi-north.com, or call 404-446-0600.

 

 

About Morrow Family Medicine and Dr. Jim Morrow

Morrow Family Medicine is an award-winning, state-of-the-art family practice with offices in Cumming and Milton, Georgia. The practice combines healthcare information technology with old-fashioned care to provide the type of care that many are in search of today. Two physicians, three physician assistants and two nurse practitioners are supported by a knowledgeable and friendly staff to make your visit to Morrow Family Medicine one that will remind you of the way healthcare should be.  At Morrow Family Medicine, we like to say we are “bringing the care back to healthcare!”  Morrow Family Medicine has been named the “Best of Forsyth” in Family Medicine in all five years of the award, is a three-time consecutive winner of the “Best of North Atlanta” by readers of Appen Media, and the 2019 winner of “Best of Life” in North Fulton County.

Dr. Jim Morrow, Morrow Family Medicine, and Host of “To Your Health With Dr. Jim Morrow”

 

Dr. Jim Morrow, Morrow Family Medicine, and Host of “To Your Health With Dr. Jim Morrow”

Dr. Jim Morrow is the founder and CEO of Morrow Family Medicine. He has been a trailblazer and evangelist in the area of healthcare information technology, was named Physician IT Leader of the Year by HIMSS, a HIMSS Davies Award Winner, the Cumming-Forsyth Chamber of Commerce Steve Bloom Award Winner as Entrepreneur of the Year and he received a Phoenix Award as Community Leader of the Year from the Metro Atlanta Chamber of Commerce.  He is married to Peggie Morrow and together they founded the Forsyth BYOT Benefit, a charity in Forsyth County to support students in need of technology and devices. They have two Goldendoodles, a gaggle of grandchildren and enjoy life on and around Lake Lanier.

Facebook: https://www.facebook.com/MorrowFamMed/

LinkedIn: https://www.linkedin.com/company/7788088/admin/

Twitter: https://twitter.com/toyourhealthMD

Show Transcript

Intro: [00:00:06] Broadcasting live from the North Fulton Business RadioX Studio. It’s time for To Your Help with Dr. Jim Morrow. To Your Health is brought to you by Morrow Family Medicine, an award-winning primary care practice, which brings the care back to health care.

Jim Morrow: [00:00:23] Good afternoon. This is To Your Health with Dr. Jim Morrow, and that’s me. I’m Jim Morrow. I’m with Morrow Family Medicine. We have an office in Milton, Georgia and in Cumming, Georgia, where we like to say we are bringing care back to health care. And we are here every second and fourth Wednesday on North Fulton Business Radio. We’re very excited to be here today. We’re doing something new and different for our show today. Today, for the first time, I have a guest with me who I’m going to be talking with about colon cancer and colon cancer screening. So, I’d like you to welcome Dr. Simon Cofrancesco from GI North in Cumming, Georgia. Hey, Simon.

Simon Cofrancesco: [00:01:01] Thanks, Jim.

Jim Morrow: [00:01:03] Good to have you.

Simon Cofrancesco: [00:01:03] Thank you very much. Glad to be here.

Jim Morrow: [00:01:05] Yeah. So, tell me a little bit about your practice and you before we get started, if you would.

Simon Cofrancesco: [00:01:09] GI North started in 2011 when I got to town, and we’ve steadily grown since then. We started out with just myself. And then, we’ve added three additional providers – two gastroenterologists and one nurse practitioner. And we’ve opened up an endoscopy center that’s just starting to get going. In addition to our clinic, it’s actually just across the hallway in a building, probably a half a mile from where you are.

Jim Morrow: [00:01:41] Well, that’s wonderful. I know you’re glad to have that up and running.

Simon Cofrancesco: [00:01:44] Absolutely.

Jim Morrow: [00:01:45] That’s got to be a good thing. So, I want to talk to you about colon cancer screening and colon cancer itself a little bit. And I know the whole thing of colon cancer screening has changed so much since you and I were in training. We went from what looked like this stand this microphone is on to what’s thankfully a lot more flexible now. But if you would, give us an overview of what a colonoscopy is all about.

Simon Cofrancesco: [00:02:14] Most people today, especially around here, know about it. It’s unusual, like you said, 20 or 30 years ago to run into somebody who’s not familiar with what it is. But it is just a long, flexible tube, very small, about like a finger in diameter, and it has a light on the end. And we just look carefully in the colon for little growths called polyps and remove those because that’s how you develop colon cancer. A slow process of a little growth called a polyp that over years gets bigger, and eventually turns into cancer.

Jim Morrow: [00:02:50] Okay. Now, speaking of colon cancer, can you talk a little bit about how many people get colon cancer and how common it is? Is it something everybody needs to be worried about and so forth?

Simon Cofrancesco: [00:02:59] Well, it really is either the second or third most common cancer in this country. And I think the number has hovered around 5%. That’s a big number, 5% of people in this country are going to get colon cancer. But the good news is, is that you can prevent that. Not catch it early but prevent that by getting a colonoscopy and removing polyps to prevent cancer.

Simon Cofrancesco: [00:03:26] So, it’s really a very different concept than most other cancers. It’s not like a mammogram where you detect breast cancer early. We prevent it. And the numbers are showing that. So, the newest numbers out show that colon cancer in people older than 50 is going down in this country over decades because people are getting screened for it. Unfortunately, the other new news is people under 50, it’s going up. So, the good news, though, is you can prevent it and they’re starting to change some of the age ranges, and it’s very prevalent, and it’s the number two cancer killer in this country.

Jim Morrow: [00:04:10] Wow. Well, that’s a wonder. I know I preach to people about going to get colonoscopies to the point, sometimes, of berating, I suppose you could say, but I certainly browbeat them if nothing else if they’re 56 or 58 and they haven’t been.

Jim Morrow: [00:04:25] So, you had one the other day, 63 years old, never been for colonoscopy. I’ve broken the bad news to him. I said, “You need two colonoscopies. You need one for when you were 50 and one for when you were 60. Lucky for you, you can make that all up in one. You don’t have to worry about it.” Now, people worry about colon cancer, but what are the signs and symptoms of colon cancer?

Simon Cofrancesco: [00:04:45] The bad news is, is that we go based on age because symptoms are not a reliable way to detect it. So, everybody thinks they’re in touch with their body. And I constantly hear, which I’m sure you hear too, “I know my body. I feel fine. There’s nothing wrong.” And it’s hard to explain to people, when you do find cancer, and it’s really a surprise that it’s probably been there for — it’s been cooking or evolving for 5 to 10 years. So, probably, one of the most common symptoms of colon cancer is that there isn’t any symptoms.

Jim Morrow: [00:05:22] Wow.

Simon Cofrancesco: [00:05:22] And that’s the scary part. But when people do get more advanced disease, some things that do show up to the patient are pain, or change in bowels, or blood in the stool. If they’re lucky enough to have those symptoms because of where the cancer is, then they may get detected at a time where they can be treated successfully. But, again, probably the cancers that we’re seeing more and more lately start in the beginning of the colon. And so, those symptoms I just mentioned are not usually as prevalent or common.

Jim Morrow: [00:05:59] Okay, good. Now, I know the thing that patients talk about the most about a colonoscopy, at least, to me, is the prep. They dread the prep because they know that they’ve got to drink, or they think they’ve got to drink this gallon of salt water, and it’s horrible. Last time I had one, I think you told me to put a packet of Crystal Light in my gallon of GoLytely. And, now, I can’t drink Crystal Light because I can’t get that taste out of my mouth, the GoLytely. But talk about the options for a prep for a colonoscopy.

Simon Cofrancesco: [00:06:30] Well, there’s been some improvement. We have smaller preps now that are about half of a soda, six ounces or so. So, it’s improved. It’s not a major improvement, but it’s an improvement. And it does make it a little easier on patients, to be honest with you, because more people can tolerate low volumes even though the taste isn’t that good. So, it’s a lot easier as far as the prep goes. It’s still the part that people don’t like.

Jim Morrow: [00:07:03] Well, if it’s only a few ounces, it must be liquid dynamite. Is that what they call it?

Simon Cofrancesco: [00:07:06] Well, it works. It works for 99% of people.

Jim Morrow: [00:07:10] I bet. I bet it does. I can just imagine. So, if we’re going through the colon, and we’re looking for things, and we found a polyp, what do you do at that point?

Simon Cofrancesco: [00:07:21] The majority of the time, we just take it out. It’s usually not big. And we have devices that can remove them. People don’t feel anything. The risk of injury to the colon is very very small. Especially today, we use devices where we don’t have to use any electricity. And that really has almost completely removed significant risks from performing a colonoscopy, but it’s just a small bump. Now, there are times where it’s big unexpectedly, and we can’t safely remove it endoscopically. And sometimes, people do have to have surgery, but that’s a real vast minority of people.

Jim Morrow: [00:08:02] And am I right in remembering that if you do that, you’ll put a tattoo on the inside of the colon?

Simon Cofrancesco: [00:08:07] Very correct. That is correct. If there’s something that we have to monitor closely or we have to alert the surgeons to, then we do put a tattoo on that. That’s correct.

Jim Morrow: [00:08:17] That’s amazing.

Simon Cofrancesco: [00:08:18] Yeah.

Jim Morrow: [00:08:18] That’s amazing. So, you mentioned a potential problem. And the other thing people talk about is I’ll say, “Well, you need a colonoscopy,” and I’ll hear, “Well, I don’t want a colonoscopy because I knew somebody that had a colonoscopy, and they had a perforation.” And, usually, at that point, I’ll say, “Well, how do you get to the office?” And they’ll say, “Well, what do you mean? I drove.” And I’ll say, “You drove an automobile? Have you not known anyone that got killed in a car wreck? Oh my God. And you drove here.” So, talk about the numbers for perforations.

Simon Cofrancesco: [00:08:51] Well, they’re changing, and they should be changing because, as I mentioned, in the last 5 to 10 years, we’re using devices that make it almost impossible to perforate somebody. Now, if something’s big, and we have to use what’s called electrocautery or electricity, that does increase the risk, but it’s still somewhere in the range of 1 in 2000. And I like your approach with the automobile. What I tell people though is the other side of the coin is that there is a rare risk of perforation, but what is your risk of colon cancer? And it’s going to be, at least, 5%. So 1 in 2000 versus, at least, 5%, which one’s less risky?

Jim Morrow: [00:09:36] I have to get the calculator, Apple, my phone, open to answer that, but I’ll do that later, I promise. So, you’re going through the colon, and you’re looking at polyps, and you pull them out, and you take them off and do a polypectomy. You send them to the lab. This is a little bit more detail than some people will want, but I think we’ve got a fairly intellectual listening audience. So, I want to give them some details about that. Can you talk a little bit about the types of polyps they might find?

Simon Cofrancesco: [00:10:01] Probably the easiest thing for me to say, and this is a big point of confusion, is that there’s two types of polyps. Not really, but I’m going to simplify it. So, there’s the kind of polyp that you have to remove because it has potential in time to turn into cancer. And then, there’s some small percentage of polyps that don’t have any potential to turn into cancer. And we see those in certain locations of the colon.

Simon Cofrancesco: [00:10:29] So, I first divided into that kind of approach. Then. you get into a lot more detail that’s probably, as you’ve mentioned, a little bit above the routine dialogue you’ll have with the patient, but there is two kinds of polyps. And there’s some that we can simply ignore because they’ll never be a problem.

Jim Morrow: [00:10:51] So, I know, until recently, it was fairly clean cut, very simple. If you had a hyperplastic polyp that doesn’t turn to cancer, you can repeat the test in five years. If you had an adenoma, the type that can turn to cancer, you’re going to repeat it in one to three years, depending on size. But you told me not long ago that that has changed. So, what should people expect in that now?

Simon Cofrancesco: [00:11:14] Yeah. The most common thing is that if people are going to have polyps, or there’s a family history of polyps or cancer, they should get a colonoscopy roughly every three to five years. It’s usually five years but depending on what we find, it can vary a little bit.

Simon Cofrancesco: [00:11:30] In people who are average risk, where they don’t have polyps, and/or nobody in their family has polyps or cancer, they can go 10 years. That shows you how slow a process colon cancer is. If we check someone today whose average risk, it would, generally speaking, take 10 years for them to start to develop colon cancer. So, it’s such a slow process, but it’s usually that 5 or 10 years.

Simon Cofrancesco: [00:11:57] And then, we do kind of bring it down under certain circumstances. There’s variables that we look at that can make us do it more frequently – the size of the polyp, how we have to remove the polyp, the specific pathology of the polyp, the number of polyps, how well they were cleaned out, avariety of different things.

Jim Morrow: [00:12:19] And the low-volume prep, as they usually call it, does a good enough job, so you don’t have to go back because you didn’t get cleaned out well in most cases.

Simon Cofrancesco: [00:12:26] The preps work but not all the time. And that’s true. Unfortunately, we disappoint about 1 out of 10 people. They have to come back because the standard prep, for whatever reason, didn’t work. Studies show that. I see that in my experience. So, there are a small group of people that will do what they’re supposed to, and it doesn’t matter whether it’s a large volume prep, Jim, or the new smaller ones.

Simon Cofrancesco: [00:12:52] The change we have in the preps today are split dose. And nobody likes this, but it does allow us to get a better examination where you take half of the prep the day before like usual, and the other half, three hours before your colonoscopy. And what that does is it keeps the colon clean on that beginning part of the colon where the bacteria start to repopulate very quickly from drinking the prep the day before. So, we don’t see as well when they do it all in one day versus plating it up. So, that’s a quality measure that us, GI doctors, are supposed to be doing to get a more thorough examination.

Jim Morrow: [00:13:34] Super. You mentioned the family history. If they do have a family history, what age do you recommend they start it?

Simon Cofrancesco: [00:13:40] A family history is either at 40 years of age, from 50 to 40, or if the person in the family, like a 45-year-old comes in, and I find a polyp on them, it would be 10 years younger than that, whichever is the youngest. So, I’m seeing polyps now, and people in their 30s and 40s, their children have to get checked 10 years before they were diagnosed with a polyp. So, we’re starting to reach downwards with colonoscopy.

Jim Morrow: [00:14:11] Well, as I tell patients too, I think very few people ever died and went to the pearly gates and said to St. Peter, “I wish I had so many colonoscopies.” But I can promise you that the opposite have been said to St. Peter.

Simon Cofrancesco: [00:14:23] Yeah.

Jim Morrow: [00:14:24] So, occasionally, patients will tell me that it was very uncomfortable when they had their colonoscopy or there were unable to finish the colonoscopy because of what’s called a torturous colon, a twisted sort of colon, curvy colon. Can you tell me a little bit about what you do in that situation and what all that means?

Simon Cofrancesco: [00:14:41] Well, first off is that if you have an experienced gastroenterologist, the chances of not completing a colonoscopy should be literally 1%, 2%, or 3%.. I mean it should be exceptional.

Jim Morrow: [00:14:55] Good.

Simon Cofrancesco: [00:14:55] So, first of all, that’s not really something that’s very common. But on occasion, it can happen. And then, if that does, by chance, happen, the testing you would have to do as an alternative would be probably some form of an x-ray or some of those tests that people who don’t want to have colonoscopy get like hemoccult testing, which is testing for microscopic blood in the stool, or there’s that relatively new DNA test cologuard. Those aren’t perfect ways. Those have limitations, but those are some of the things that you can do. It should be exceptional that a colonoscopy cannot be completed, just so you know.

Jim Morrow: [00:15:34] So, you mentioned cologuard. I was going to get to that because I get asked that daily, it seems like. What do you tell patients about why the colonoscopy is a preferred test to cologuard?

Simon Cofrancesco: [00:15:46] Cologuard has a lot of limitations. It’s not meant to pick up polyps, first of all. It picks up cancer. So, you’re already moving away from something that can prevent cancer, and you’re moving into something that diagnoses cancer. Big difference there, right? Number one.

Simon Cofrancesco: [00:16:07] Number two. Although the studies say that it’s supposed to be accurate or specific 85% of the time, I think not, just myself but everybody I’ve spoken to will say that it’s not the case. Probably the last 20 people I’ve scoped with a positive cologuard have not had colon cancer. So, it’s been wrong.

Simon Cofrancesco: [00:16:32] And then, finally, the biggest thing about cologuard is that patients and doctors don’t know what it’s indicated for. It’s very narrow indication. It’s not for everybody. It’s for average-risk individuals. So, if they have had polyps, or cancer, and/or if somebody else in their family has had polyps or cancer – in other words, a high-risk individual – it’s not intended for them because those people have a high rate of polyps, and the cologuard test will not tell you if they have polyps.

Simon Cofrancesco: [00:17:07] So, it’s very narrow, but, in reality, I know that people get it, and I don’t blame you for what you do or anybody else, is that they’re just not going to have a colonoscopy. And this is probably the best you can do. So, that’s real world. People ask me, who’s the cologuard for? I tell them it’s for chickens because it’s just for people who don’t want to have the best test because they’re scared, or frightened, or things like that.

Jim Morrow: [00:17:31] They’ve been reading on the internet about colonoscopies.

Simon Cofrancesco: [00:17:34] Yeah. And like you say, it’s very anecdotal. They’ll hear about — you do hear about that one person who had a tragic complication, but they don’t hear about the thousands of people that they don’t mention it because it was no big deal.

Jim Morrow: [00:17:49] Yeah. And after a colonoscopy, what should patients expect post-op, if you will? I know it’s not an operation. But after the colonoscopy, what’s the rest of their day likely to be like?

Simon Cofrancesco: [00:17:59] I have to say it should be normal. I mean, the biggest thing when they wake up is going to be just the sedation wearing off, and what they’ve just been through the day before by not eating, and maybe some electrolyte disturbances. They may feel tired a little. They’ve been getting up very early to finish the second half of their prep. So, the biggest thing is this, people are going to probably be a little bit fatigued or tired after sedation, and not eating regularly, and maybe some mild electrolyte abnormalities.

Simon Cofrancesco: [00:18:30] But here’s a nice thing, I’ll put a little plug in for our practice. We have scopes now where we are that we don’t use air to put into the colon. We use CO2. So, that bloating, and distention, and air feeling that some people got, or cramping, they won’t have that at our place because we have CO2, for instance, which was probably the most common complaint – feeling bloated, or distended, or cramping. So, barring a rare complication, most people are just pretty normal after the procedure. They can eat normal. They can’t drive but everything else is pretty much the same.

Jim Morrow: [00:19:10] And they can’t drive because they’ve been sedated. In these days, you’re using Propofol. Is that right?

Simon Cofrancesco: [00:19:15] Which is ultra quick, and it wears off quick. And people feel great. They really feel like they can drive, but, still, their motor skills probably aren’t up to snuff, and that’s even though they feel like they are.

Jim Morrow: [00:19:28] Right. And by that, Propofol was what Michael Jackson used to go to sleep at night for years, and years, and years, which is a little bit of a problem, which is why his doctor is in jail right now.

Simon Cofrancesco: [00:19:39] Yeah. And that came up a lot. When that first happened with Michael Jackson, a lot of patients were very scared. And all I can convince people and tell people about is I’ve been using Propofol for my patients for probably 20 to 25 years right before we were using Versed and so forth. And it’s a perfect drug for endoscopy. In fact, when I have my colonoscopy, that’s what I have, Propofol.

Jim Morrow: [00:20:04] Which is incredibly safe, and people just don’t realize the one-off that they’re doing is nothing compared to anything else. So, I think it’s a great choice. I’m glad you’re using it now. I know when I had mine done, it was a nothing event.

Simon Cofrancesco: [00:20:17] Exactly, exactly.

Jim Morrow: [00:20:18] [Crosstalk] is just a nothing event. So, with the colonoscopy, you’re going through there, you’re looking for polyps, but I know there are other things that you might find. It doesn’t relate directly to colon cancer screening, but talk about some of the other things you might find – the inflammation, and bleeding, and so forth, and so on.

Simon Cofrancesco: [00:20:37] Yeah, the most common thing we see is polyps or actually second most common thing because everybody’s got diverticulosis. I’ll mention that. It’s very unusual in this country that I do a colonoscopy on someone 50 or older and don’t see diverticulosis. So, fortunately though, most people won’t be bothered by that. Only a small percentage will get an infection called diverticulitis.

Simon Cofrancesco: [00:20:59] So, that is the most common abnormal finding, and we don’t really do anything about it except, excuse me, encourage people to eat more fiber, and to take a fiber supplement every day. Actually, I encourage everybody to take a fiber supplement every day. It’s an important part of our diet that we are missing in this country. We just don’t get enough fiber. So, with or without diverticulosis, I think it’s a good idea, but especially with diverticulosis.

Simon Cofrancesco: [00:21:26] And then, probably, the next most common thing that we see is inflammatory conditions, which you’ve already kind of alluded to. And they can be infections, or, very commonly, it can be autoimmune conditions like Crohn’s disease or ulcerative colitis. We see a lot of autoimmune conditions. It’s very common. It’s not diminishing. In fact, I think it’s probably becoming more common in my practice to see somebody with Crohn’s or ulcerative colitis. And then, there’s a smattering of less common diseases that cause inflammation.

Jim Morrow: [00:22:00] And with insurance coverage today, most insurance companies that I know of these days cover a screening colonoscopy. Is that right?

Simon Cofrancesco: [00:22:08] Yes, they do. And the problem is it’s very complicated, but you’re correct. If someone has no history of colon cancer, colon polyps, they get screening, but it’s funny how the insurance companies play games. And if your family history was positive, or you have irritable bowel syndrome or symptoms, or you’ve had a polyp in the past, they try to change things, or if I remove something during a screening colonoscopy, it changes. So, my perspective on that is it’s become a very tricky thing. It’s become a game, and you know how insurance companies do that.

Jim Morrow: [00:22:50] True.

Simon Cofrancesco: [00:22:50] And we were constantly struggling to placate the insurance companies on this and help our patients. It’s kind of a little conflictual.

Jim Morrow: [00:23:01] Okay. Yeah. So, while you’ve got patients, so there are a lot of times when the patients will come to me, and they’ll be taking Prilosec or the generic version and take it every single night. If they don’t take it for two days, they have horrible heartburn. So, while we’re staying in the endoscopy suite, sort of, you can look for ulcers by doing an upper endoscopy, not just a colonoscopy. So, how is that procedure done?

Simon Cofrancesco: [00:23:30] Upper endoscopy is a much quicker test. You don’t have to prepare for it. It takes about 10 minutes. All you do is skip your breakfast, put in an IV, and then people take a nap for 5 or 10 minutes. They won’t know anything was done. Just like a colonoscopy, they’ll wake up speaking to the nurse like when are they going to start. So, like you said about your experience, there is no experience.

Simon Cofrancesco: [00:23:51] And we look carefully at the esophagus, stomach, and do a DME, which is basically the upper GI tract. Commonly, we see diseases of the esophagus. It’s very common, probably more so now than stomach disorders, believe it or not. Ulcer disease was the king when I was starting out in the early ’90s. And it’s funny how it’s shifted esophageal diseases have become much more common. Maybe it’s because of the medications we have over the counter. Maybe it’s because of H.pylori being treated so much. But esophageal diseases make up a big part of what gastroenterologists take care of in the upper part.

Jim Morrow: [00:24:29] I think every time I mentioned to a patient that they can do the two tests at the same time, their biggest question is, will they use a different scope? And I assure them that they will. And if they don’t, ask them to do the upper first. That way, it doesn’t really matter.

Simon Cofrancesco: [00:24:44] Yeah. I joke around, and I tell them it depends on their insurance.

Jim Morrow: [00:24:50] I’ll have to remember that. I love that. So, John’s over here acting like he has some question for us. We’re here in the studio at Renasant Bank on Windward Parkway. And we’ve got John Ray here in North Fulton Business Radio. John’s got some questions from listeners.

John Ray: [00:25:05] That’s right.

Jim Morrow: [00:25:05] What you got, John? How are you doing?

John Ray: [00:25:07] I’m good. How are you?

Jim Morrow: [00:25:08] Good. This is my first guest.

John Ray: [00:25:10] I know. You did a great job.

Jim Morrow: [00:25:11] I’m nervous as a cat.

John Ray: [00:25:13] Why?

Jim Morrow: [00:25:13] I don’t know, but I am.

John Ray: [00:25:15] Well, he’s the one that had to have all the answers today. Usually, it’s you.

Jim Morrow: [00:25:20] I count on him too.

John Ray: [00:25:22] Okay. Well, here’s a couple of questions that we’ve got that have come in. So, this question is about blood in the stool. Does that automatically mean I have colorectal cancer?

Simon Cofrancesco: [00:25:37] Absolutely not. If I looked at all comers with that problem, fortunately, it’s a minority, but it’s important for us to make sure that it isn’t colon cancer. But in many instances, it’s something very insignificant or small that we can easily take care of, hemorrhoids, et cetera.

Jim Morrow: [00:25:59] So, along those lines — let me jump in there, John.

John Ray: [00:26:01] Sure.

Jim Morrow: [00:26:02] If someone comes to me, their family doctor, and says ” I have some blood in my stool,” do I send them straight to you?”

Simon Cofrancesco: [00:26:11] I guess, if it’s been a few years since they’ve had a colonoscopy, and if they’re not young like 20 or 25, it does kind of get into that mode where there might be a concern about liability because today, it’s hard to ignore an adult who has blood in the stool, who hasn’t had a recent colonoscopy. I’d say it’s almost a no-brainer, but there are some circumstances where you could probably just say, “Let’s try to treat you for hemorrhoids first because you had a colonoscopy a year or two ago,” or something like that.

Jim Morrow: [00:26:47] Well, it’s good to know I’m doing that, right? Because I do know that one of the worst things I hear is when you hear about a patient, 36 years old, that actually died from colon cancer because it does happen, and you talked about that earlier. And if anybody gets anything from this, I hope they’ll get it, they need to go for colonoscopy. What else you got, John?

Simon Cofrancesco: [00:27:07] So, I want to say something about that because I, actually, last year, had a young man with no family history who came to me with what sounded like hemorrhoidal bleeding, and I wiped the sweat off my brow after I scoped him because he had colon cancer. So, your experience with a 30-year-old, and I’ll just tell you why you got to pay attention, and I didn’t mean to say you don’t pay attention when they’re younger because I’ve clearly had people — fortunately, this young man survived and has done very well, but I see all age groups. And so, it gets tricky, but it’s a no-brainer when they’re mid 40s and 50s, and they have blood, and you just got to get checked.

Jim Morrow: [00:27:49] Right, right.

Simon Cofrancesco: [00:27:49] Yeah.

John Ray: [00:27:50] So, you’re hitting something on that this next question gets at right now, which is you mentioned the earlier incidents of colorectal cancer. So, is every 10 years enough?

Simon Cofrancesco: [00:28:07] I can just tell you about my experiences is that it works well the vast majority of times. The screening procedures are set up not to be perfect. They’re not perfect. And I hate to have to explain common sense to people. We don’t have perfect tests, and we don’t have unlimited resources, so they draw a line somewhere that gets almost everybody. But yeah, 10 years is a long time. And when that first was incorporated, a lot of us were very uncomfortable. As it’s panned out over the years, I don’t see a lot of people getting burned, but it’s not perfect. Some people will.

John Ray: [00:28:51] Now, one other age-related question. This comes from a listener talking about her mom. At what point does a patient’s age make a colonoscopy more of a problem than it’s worth?

Jim Morrow: [00:29:03] Good question.

Simon Cofrancesco: [00:29:03] Yeah, that’s an excellent question, and there’s no simple answer to that. I go through that every day. Everybody’s very focused on the number. The first thing I’d say is the number starts the conversation. So, to give you an example, I have an 85-year-old gentleman, and this is not an isolated situation. I have lots of people like this in their mid-80s, highly functioning. They just finished mowing their lawn, they drove themselves in, and I diagnosed them with colon cancer six years ago, and they want their colonoscopy. So, they’re a high-risk individual, and they’re highly functioning. That person has already broken the curve on the age thing.

Jim Morrow: [00:29:39] Right.

Simon Cofrancesco: [00:29:40] So, I do a colonoscopy. And I have lots of those people, and they do great. And then, I have somebody who comes in who’s 75, who’s not doing well. They’re just not healthy. And they have a limited life expectancy. Maybe three, four, or five more years left. They haven’t had polyps, or there’s no high risk. That person clearly doesn’t need a colonoscopy. The risk of the colonoscopy might be greater because their risk of cancer is low.

Simon Cofrancesco: [00:30:08] So, I mean, age is, to me, something that you start a dialogue with. And then you have to look at both sides. What’s the risk for the patient of the procedure, and what are their risks possibly of having colon cancer? And then, I get with the patient. And then, we come together on a decision because, many times, sometimes, I do a procedure because the patient wants me to because they’re concerned because their dad had colon cancer, and they don’t want to get colon cancer. And that may make us favor doing a colonoscopy. So, it’s not an easy answer, and it’s a case-by-case basis.

John Ray: [00:30:43] Peace of mind is an incredible commodity. I tell people you should get all you can get.

Simon Cofrancesco: [00:30:49] It can be therapeutic for some people. Jim and I see people everyday that suffer from anxiety. I mean, it’s real, especially as people get older. They get more fragile. And you can give them peace of mind. And if you’re smart, and you’ve done this, we’re not hurting older people, but there’s definitely people that are older that safely can have colonoscopy.

John Ray: [00:31:13] Great.

Jim Morrow: [00:31:13] That’s it?

John Ray: [00:31:14] That’s it.

Simon Cofrancesco: [00:31:15] That’s it.

Jim Morrow: [00:31:16] Well, good. Well, this is Dr. Jim Morrow. And, again, I want you to know that I’m with Morrow Family Medicine. At Morrow Family Medicine, we use technology and old-fashioned attitudes to do our very best to make you feel better every day. We’re located in Milton and Cumming, Georgia. Our website for the show is toyourhealth.md. If you want to send us a question or a show topic you might want us to try, the email is drjim@toyourhealth.md, or you can tweet us @toyourhealthmd. And Dr. Simon Cofrancesco, if you would tell us a little bit about how patients can get in touch with you, and come see you, or one of your partners.

Simon Cofrancesco: [00:31:55] Absolutely. Thanks, Jim. GI North. And the phone number is 404-446-0600. They can also look at our website, ginorth.com. And I believe our web site is GI-north — I’m blanking out right there. Help me out here.

Jim Morrow: [00:32:19] His marketing director is right behind him.

Simon Cofrancesco: [00:32:21] Unfortunately, my marketing director doesn’t remember our website. So I apologize.

Jim Morrow: [00:32:27] We’ll have it in the show notes. This is great. I love it. Well, I do appreciate everybody listening. And if you are enjoying the show and the podcast, wherever you’re listening, hit the subscribe button, so you can be sure and be notified when there’s another episode. I really want to thank Dr. Simon Cofrancesco for being my first guest on the show and for coming on with us. It’s great.

Jim Morrow: [00:32:49] In two weeks, we’re going to have a very interesting show, a little bit different also. This is going to be an interview with Derek Bailey from the Right Move. They specialize in helping your seniors find a good location and a good solution to whatever their residential situation might be. So, we’re going to talk with Derek in two weeks. And until then, that is To Your Health.

Tagged With: Crohn's disease, Cumming doctor, Cumming family medicine, Cumming family practice, Cumming healthcare, Cumming md, Cumming primary care, diverticulitis, Diverticulosis, Dr. Jim Morrow, fiber supplement, gastroenterologist, gastroenterology, GI North, Healthcare, incidence of colon cancer, inflamatory bowel disease, inflammation, Irritable Bowel Syndrome, Milton doctor, Milton family doctor, Milton family medicine, Milton family practice, Milton md, Morrow Family Medicine, polyp, rectal bleeding, rectal cancer

Business RadioX ® Network


 

Our Most Recent Episode

CONNECT WITH US

  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Our Mission

We help local business leaders get the word out about the important work they’re doing to serve their market, their community, and their profession.

We support and celebrate business by sharing positive business stories that traditional media ignores. Some media leans left. Some media leans right. We lean business.

Sponsor a Show

Build Relationships and Grow Your Business. Click here for more details.

Partner With Us

Discover More Here

Terms and Conditions
Privacy Policy

Connect with us

Want to keep up with the latest in pro-business news across the network? Follow us on social media for the latest stories!
  • Email
  • Facebook
  • Google+
  • LinkedIn
  • Twitter
  • YouTube

Business RadioX® Headquarters
1000 Abernathy Rd. NE
Building 400, Suite L-10
Sandy Springs, GA 30328

© 2025 Business RadioX ® · Rainmaker Platform

BRXStudioCoversLA

Wait! Don’t Miss an Episode of LA Business Radio

BRXStudioCoversDENVER

Wait! Don’t Miss an Episode of Denver Business Radio

BRXStudioCoversPENSACOLA

Wait! Don’t Miss an Episode of Pensacola Business Radio

BRXStudioCoversBIRMINGHAM

Wait! Don’t Miss an Episode of Birmingham Business Radio

BRXStudioCoversTALLAHASSEE

Wait! Don’t Miss an Episode of Tallahassee Business Radio

BRXStudioCoversRALEIGH

Wait! Don’t Miss an Episode of Raleigh Business Radio

BRXStudioCoversRICHMONDNoWhite

Wait! Don’t Miss an Episode of Richmond Business Radio

BRXStudioCoversNASHVILLENoWhite

Wait! Don’t Miss an Episode of Nashville Business Radio

BRXStudioCoversDETROIT

Wait! Don’t Miss an Episode of Detroit Business Radio

BRXStudioCoversSTLOUIS

Wait! Don’t Miss an Episode of St. Louis Business Radio

BRXStudioCoversCOLUMBUS-small

Wait! Don’t Miss an Episode of Columbus Business Radio

Coachthecoach-08-08

Wait! Don’t Miss an Episode of Coach the Coach

BRXStudioCoversBAYAREA

Wait! Don’t Miss an Episode of Bay Area Business Radio

BRXStudioCoversCHICAGO

Wait! Don’t Miss an Episode of Chicago Business Radio

Wait! Don’t Miss an Episode of Atlanta Business Radio